University of Kentucky
Lexington, Kentucky, 40508, United States
NCT Number: NCT06508996
A multi-site prospective, all comers study that was conducted at geographically diverse locations in the United States.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lexington, Kentucky, 40508, United States
Whole blood specimens were collected from consented individuals with signs and symptoms and/or individuals at-risk of HCV infection, irrespective of HCV antibody status at a single timepoint.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Detection of HCV RNA by Xpert HCV test
Time frame: 1 day
Clinical performance comparing Xpert test to PIS (NAAT + Antibody status)
Cepheid
Industry
Clinical Evaluation of the Xpert® HCV Test on the GeneXpert® Xpress System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07569211
Blood-Borne Infections, Chemically-Induced Disorders
Kyiv, Ukraine
View Trial DetailsNCT03221309
Buprenorphine, HCV
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05454579
Communicable Diseases, Disease Attributes
Pasay, Manila, Philippines
View Trial DetailsNCT05904470
Blood-Borne Infections, Chronic Disease
San Antonio, Texas, United States
View Trial Details